covid moderna vaccine

rna, H5 bird flu

Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.

STAT · 2d

Pharmalittle: We’re reading about a cancelled FDA vaccine meeting, a Moderna bird flu vaccine, and more

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for the next flu season

Barron's on MSN · 2d

Moderna Stock Falls on Report HHS Is Reviewing Bird Flu Vaccine Contract

Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services Department was re-evaluating its $590 million contract to develop a bird flu vaccine.

2don MSN

Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.

Rolling Out5d

What to know about the latest vaccine updates

COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...

Time4y

COVID-19 Vaccine Tracker

A guide to the coronavirus vaccination rollout and what you need to know about the authorized vaccines Some 63.8% of Americans have received both doses of the two-shot Pfizer-BioNTech and ...

14don MSN

Moderna's Q4 Loss Wider Than Expected

The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 ...

15d

Moderna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides

Moderna Inc. (NASDAQ:MRNA) reported a fourth-quarter EPS loss of $(2.91), missing the consensus of $(2.62), a turnaround from ...

ABC News14d

COVID-19 Vaccine

Here's what you need to know about the possible next generation of shots. Moderna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels comparable to ...

The Motley Fool2y

Investing in Vaccine Stocks

COVID-19 vaccine sales have declined, but other vaccines are still growth drivers for several companies. Top vaccine stocks for investors to consider include Pfizer and Moderna. Other ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results